Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor

Circulation Research

Volumn 82, Issue 12, 1998, Pages 1338-1348

  Murasawa, Satoshi ^a   Mori, Yasukiyo ^a   Nozawa, Yoshihisa ^b   Gotoh, Noriko ^c   Shibuya, Masabumi ^a   Masaki, Hiroya ^a   Maruyama, Katsuya ^a   Tsutsumi, Yoshiaki ^a   Moriguchi, Yasutaka ^a   Shibazaki, Yasunobu ^a   Tanaka, Yohko ^a   Iwasaka, Toshiji ^a   Inada, Mitsuo ^a   Matsubara, Hiroaki ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiotensin II; Angiotensin II receptor; Ca2+; Epidermal growth factor receptor; G protein coupled receptor

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; GENE EXPRESSION; HEART VENTRICLE REMODELING; MITOGENESIS; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0032577953     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.12.1338     Document Type: Article

References (61)

1. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54: 227-241.
2. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83: 1849-1865.
3. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993;72:1245-1254.
4. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann W. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 1993;88:2849-2861.
5. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Masaki H, Murasawa S, Kijima K, Maruyama K, Iwasaka T, Inada M. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation. 1997;96:3954-3962.
6. Smits JFM, van Krimpen C, Shoemaker RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiavasc Pharmacol. 1992;20:772-778.
7. Inagami T, Kitami Y. Angiotensin II receptor: molecular cloning, functions and regulation. Hypertens Res. 1994;17:87-97.
8. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res. 1997;80:607-616.
9. 2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts. Am J Physiol. 1994;267:C1308-C1318.
10. Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem. 1994;269:19626-19632.
11. Bernstein KE, Marrero MB. The importance of tyrosine phosphorylation in angiotensin II signaling. Trends Cardiovasc Med. 1996;6:179-187.
12. Zou Y, Komuro I, Yamazaki T, Aikawa R, Kudoh S, Shiojima I, Hiroi Y, Mizuno T, Yazaki Y. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J Biol Chem. 1996;27:33592-33597.
13. ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J. 1996;15:775-787.
14. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. J Biol Chem. 1996;271:14169-14175.
15. Cano E, Mahadevan LC. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci. 1995;20:117-122.
16. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 1992;9:383-391.
17. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T, Pelicci PG. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 1992;70:93-104.
18. Linseman DA, Benjamin CW, Jones DA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem. 1995;270:12563-12568.
19. Eguchi S, Motley E, Numaguchi K, Matsumoto T, Utsunomiya H, Yamakawa T, Hirata Y, Inagami T. EGF receptor transmits the angiotensin II-induced growth promoting signal in vascular smooth muscle cells [abstract]. Hypertension. 1997;30:473.
20. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors. Nature. 1996; 379:557-560.
21. Luttrell LM, Della Rocca J, van Biesen T, Luttrell DK, Lefkowitz RJ. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. J Biol Chem. 1997;272:4637-4644.
22. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 1997;16: 7032-7044.
23. Zwick E, Daub H, Aoki N, Yamaguchi-Aoki Y, Tinhofer I, Maly K, Ullrich A. Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem. 1997;272:24767-24770.
24. Rosen LB, Greenberg ME. Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc Natl Acad Sci USA. 1996;93:1113-1118.
25. Showkat Ali M, Schieffer B, Delafontaine P, Bernstein KE, Ling BN, Marrero MB. Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells. J Biol Chem. 1997;272: 12373-12379.
26. Tsai W, Moreielli AD, Peralta EG. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J. 1997;16:4597-4605.
27. Matsubara H, Kanasaki M, Murasawa S, Tsukaguchi Y, Nio Y, Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest. 1994;93:1592-1601.
28. Kijima K, Matsubara H, Murasawa S, Maruyama K, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaka T, Inada M. Mechanical stretch induces enhanced expression of angiotensin II receptors in neonatal rat cardiac myocytes. Circ Res. 1996;79:887-897.
29. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439-447.
30. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46-54.
31. Gotoh N, Tojo A, Muroya K, Hashimoto Y, Hattori S, Nakamura S, Takenawa T, Yazaki Y, Shibuya M. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity. Proc Natl Acad Sci U S A. 1994;91:167-171.
32. Murasawa S, Matsubara H, Kijima K, Maruyama K, Ohkubo N, Mori Y, Iwasaka Y, Iwasaka T, Inada M. Down-regulation by cAMP of angiotensin II type2 receptor gene expression in PC12 cells. Hypertens Res. 1996;19:271-279.
33. Bowen-Pope DF, Ross R. Methods for studying the platelet-derived growth factor receptor. Methods Enzymol. 1985;109:69-100.
34. Redemann N, Holzmann B, Rden T, Wagner EF, Schlessinger J, Ullrich A. Anti-oncogenic activity of signaling-defective epidermal growth factor receptor mutants. Mol Cell Biol. 1992;12:491-498.
35. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 1995;267:1782-1787.
36. Okada S, Kao AW, Ceresa BP, Blaikie P, Margolis B, Pessin JE. The 66-kDa She isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem. 272;44:28042-28049.
37. Kao AW, Waters SB, Okada S, Pessin JE. Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways. Endocrinology. 1997;138:2474-2480.
38. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247-250.
39. Bhat GJ, Thekkumkara TJ, Thomas WG, Conrad KM, Baker KM. Angiotensin II stimulates sis-inducing factor-like DNA binding activity. J Biol Chem. 1994;269:31443-31449.
40. Hill CS, Wynne J, Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42 Hs regulates transcriptional activation by SRF. Cell. 1995; 81:1159-1170.
41. Cavigelli M, Dolfi F, Claret FX, Karin M. Induction of c-fos expression through JNK-mediated TCF/ELK-1 phosphorylation. EMBO J. 1995;14: 5957-5964.
42. Marais R, Light Y, Paterson HF, Marshall CJ. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 1995;14:3136-3145.
43. Fabian JR, Daar IO, Morrison DK. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol Cell Biol. 1993; 13:7170-7179.
44. Huckle WR, Prokop CA, Dy RC, Herman B, Earp S. Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner. Mol Cell Biol. 1990;10:6290-6298.
45. Leduc I, Meloche S. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem. 1995;270:4401-4404.
46. Liao DF, Duff JL, Daum G, Pelech SL, Berk BC. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells: role of Raf. Circ Res. 1996;79:1007-1014.
47. Castoria G, Migliaccio A, Green S, Domenico MD, Chambon P, Auricchio F. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry. 1993;32:1740-1750.
48. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G protein-coupled receptors with MAP kinase activation. Nature. 1996;383:547-550.
49. 2+-induced regulation of ion channel and MAP kinase functions. Nature. 1995;376:737-744.
50. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
51. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev. 1994;4:96-101.
52. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cob MH, Shaw PE. ERK phosphorylation potentiates ELK-1-mediated ternary complex formation and transactivation. EMBO J. 1995;14:951-962.
53. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 1987;49:729-739.
54. 2-terminal kinases in cultured cardiac myocytes of neonatal rats. Circ Res. 1997;80:139-146.
55. Derijiard B, Hibi M, Wu I, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1 : a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994;76:1025-1037.
56. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994;369:156-160.
57. Sanchez I, Hughes TR, Mayer JB, Yee K, Woodgett RJ, Avruch J, Kyriakis MJ, Zon IL. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-jun. Nature. 1994;372:794-798.
58. Nobes CD, Hall A. Regulation and function of the Rho subfamily of small GTPases. Curr Opin Genet Dev. 1994;4:77-81.
59. Minden A, Lin A, Claret FX, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPase Rac and Cdc42Hs. Cell. 1995;81:1147-1157.
60. Kovacic-Milivojevic B, Gardner DG. Divergent regulation of the human atrial natriuretic peptide gene by c-fos. Mol Cell Biol. 1992;12:292-301.
61. The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med. 1992;327:669-677.